Ridgewood Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Sell
445
-45
-9% -$46K 0.2% 138
2026
Q1
$451K Buy
+490
New +$497K 0.18% 145
2025
Q3
$352K Buy
461
+83
+22% +$61.8K 0.15% 160
2025
Q2
$295K Sell
378
-68
-15% -$52.8K 0.13% 170
2025
Q1
$368K Buy
446
+19
+4% +$15.8K 0.17% 137
2024
Q4
$330K Hold
427
0.16% 141
2024
Q3
$378K Buy
427
+12
+3% +$10.8K 0.19% 123
2024
Q2
$375K Hold
415
0.19% 133
2024
Q1
$323K Hold
415
0.17% 145
2023
Q4
$242K Sell
415
-8
-2% -$4.67K 0.14% 154
2023
Q3
$227K Hold
423
0.15% 147
2023
Q2
$198K Hold
423
0.11% 169
2023
Q1
$145K Buy
+423
New +$143K 0.09% 215
2017
Q4
Sell
-2,691
Closed -$230K 148
2017
Q3
$230K Sell
2,691
-84
-3% -$6.89K 0.22% 126
2017
Q2
$228K Sell
2,775
-37
-1% -$3.02K 0.23% 123
2017
Q1
$237K Sell
2,812
-6
-0.2% -$481 0.25% 113
2016
Q4
$207K Buy
+2,818
New +$210K 0.24% 109

Other funds holding LLY

Ridgewood Investments's LLY Position: Q2 2026 in Review

Ridgewood Investments reduced its Eli Lilly (LLY) stake by 9.2% in Q2 2026, selling an estimated $46K and leaving 445 shares worth $534K. The position accounts for 0.2% of the portfolio, ranked #138.

Ridgewood Investments first reported a position in LLY in Q4 2016 and has held it in 17 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ridgewood Investments held 445 shares of Eli Lilly worth $534K as of Q2 2026.
  • Ridgewood Investments sold 45 Eli Lilly shares in Q2 2026, an estimated $46K.
  • Eli Lilly made up 0.2% of Ridgewood Investments's portfolio in Q2 2026, its #138 holding.
  • Ridgewood Investments first reported a position in Eli Lilly in Q4 2016 and has held it in 17 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ridgewood Investments's 13F filing for Q2 2026, filed 3 Aug 2026.